Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the injections will be given out from March, the health service is too ...

Tirzepatide, available as Mounjaro, has been hailed as the 'King Kong' of slimming jabs — more effective for shifting the pounds than similar drugs like Ozempic. Yesterday the NHS spending ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold ...

NHS England requested that Mounjaro be rolled out over a period of 12 years Credit: GEORGE FREY In a submission to Nice, NHS England had pleaded for a slow rollout in order to allow time to set up ...

The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro, dubbed the "King Kong of weight loss jabs", has recommended the drug be administered to NHS patients ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related ...

Health officials revealed on Thursday they are prioritising the drug for people with the highest needs. The “difficult decision” was made “in order to protect other vital NHS services ...

Weight-loss injection Mounjaro, also known as tirzepatide, could offer hope to those suffering from obesity when it is rolled out on the NHS over a 12-year period. The National Institute for Health ...